Listed

Dyne Therapeutics, Inc.

DYNNasdaqCIK 1818794HealthcareFiscal year ends Dec 31

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$181.7m, Q2 FY2026
Net income−$178.6m, Q2 FY2026
Dyne Therapeutics, Inc., income statement, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m55.3Research and development, Q3 FY2023, three months to 2023-09-30$55.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2024-11-12, accession 0000950170-24-124572.Report this figure58.8Research and development, Q4 FY2023, three months to 2023-12-31$58.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure44.5Research and development, Q1 FY2024, three months to 2024-03-31$44.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-05-08, accession 0000950170-25-066386.Report this figure62.3Research and development, Q2 FY2024, three months to 2024-06-30$62.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-07-28, accession 0000950170-25-099161.Report this figure92.8Research and development, Q3 FY2024, three months to 2024-09-30$92.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure81.8Research and development, Q4 FY2024, three months to 2024-12-31$81.8m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure106Research and development, Q1 FY2025, three months to 2025-03-31$106.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure99.2Research and development, Q2 FY2025, three months to 2025-06-30$99.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure97.2Research and development, Q3 FY2025, three months to 2025-09-30$97.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure95.4Research and development, Q4 FY2025, three months to 2025-12-31$95.4m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure101Research and development, Q1 FY2026, three months to 2026-03-31$100.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure152Research and development, Q2 FY2026, three months to 2026-06-30$152.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure
Operating income$m(62.3)Operating income, Q3 FY2023, three months to 2023-09-30−$62.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-124572.Report this figure(67.7)Operating income, Q4 FY2023, three months to 2023-12-31−$67.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure(69.2)Operating income, Q1 FY2024, three months to 2024-03-31−$69.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-05-08, accession 0000950170-25-066386.Report this figure(72.0)Operating income, Q2 FY2024, three months to 2024-06-30−$72.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-07-28, accession 0000950170-25-099161.Report this figure(106)Operating income, Q3 FY2024, three months to 2024-09-30−$105.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure(97.1)Operating income, Q4 FY2024, three months to 2024-12-31−$97.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure(122)Operating income, Q1 FY2025, three months to 2025-03-31−$122.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure(116)Operating income, Q2 FY2025, three months to 2025-06-30−$115.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure(114)Operating income, Q3 FY2025, three months to 2025-09-30−$113.9m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure(116)Operating income, Q4 FY2025, three months to 2025-12-31−$116.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure(125)Operating income, Q1 FY2026, three months to 2026-03-31−$125.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure(182)Operating income, Q2 FY2026, three months to 2026-06-30−$181.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure
Interest expense$mnot reportednot reportednot reportednot reported0.0Interest expense, Q3 FY2024, three months to 2024-09-30$0. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figurenot reportednot reported0.1Interest expense, Q2 FY2025, three months to 2025-06-30$94.0k. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-07-28, accession 0000950170-25-099161.Report this figure2.9Interest expense, Q3 FY2025, three months to 2025-09-30$2.9m. XBRL concept us-gaap:InterestExpense. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figurenot reportednot reportednot reported
Net income$m(60.2)Net income, Q3 FY2023, three months to 2023-09-30−$60.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2024-11-12, accession 0000950170-24-124572.Report this figure(66.6)Net income, Q4 FY2023, three months to 2023-12-31−$66.6m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure(65.6)Net income, Q1 FY2024, three months to 2024-03-31−$65.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure(65.1)Net income, Q2 FY2024, three months to 2024-06-30−$65.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure(97.1)Net income, Q3 FY2024, three months to 2024-09-30−$97.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure(89.5)Net income, Q4 FY2024, three months to 2024-12-31−$89.5m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure(115)Net income, Q1 FY2025, three months to 2025-03-31−$115.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure(111)Net income, Q2 FY2025, three months to 2025-06-30−$110.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure(108)Net income, Q3 FY2025, three months to 2025-09-30−$108.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure(112)Net income, Q4 FY2025, three months to 2025-12-31−$112.0m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure(121)Net income, Q1 FY2026, three months to 2026-03-31−$120.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure(179)Net income, Q2 FY2026, three months to 2026-06-30−$178.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure
Diluted EPS$ per share(0.99)Diluted EPS, Q3 FY2023, three months to 2023-09-30−$0.99 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2024-11-12, accession 0000950170-24-124572.Report this figurenot reported(0.81)Diluted EPS, Q1 FY2024, three months to 2024-03-31−$0.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-05-08, accession 0000950170-25-066386.Report this figure(0.70)Diluted EPS, Q2 FY2024, three months to 2024-06-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-07-28, accession 0000950170-25-099161.Report this figure(0.96)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$0.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figurenot reported(1.05)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$1.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure(0.97)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.97 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure(0.76)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figurenot reported(0.73)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.73 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure(1.08)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.08 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure
Basic EPS$ per share(0.99)Basic EPS, Q3 FY2023, three months to 2023-09-30−$0.99 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2024-11-12, accession 0000950170-24-124572.Report this figurenot reported(0.81)Basic EPS, Q1 FY2024, three months to 2024-03-31−$0.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-05-08, accession 0000950170-25-066386.Report this figure(0.70)Basic EPS, Q2 FY2024, three months to 2024-06-30−$0.70 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-07-28, accession 0000950170-25-099161.Report this figure(0.96)Basic EPS, Q3 FY2024, three months to 2024-09-30−$0.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figurenot reported(1.05)Basic EPS, Q1 FY2025, three months to 2025-03-31−$1.05 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure(0.97)Basic EPS, Q2 FY2025, three months to 2025-06-30−$0.97 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure(0.76)Basic EPS, Q3 FY2025, three months to 2025-09-30−$0.76 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figurenot reported(0.73)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.73 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure(1.08)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.08 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure

Balance sheet

Cash and equivalents$676.1m, Q2 FY2026
Long-term debt$199.3m, Q2 FY2026
Shareholders' equity$702.2m, Q2 FY2026
Dyne Therapeutics, Inc., balance sheet, quarterly
Line itemUnitQ3 FY20232023-09-30FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$m130Cash and equivalents, Q3 FY2023, at 2023-09-30$130.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2023-10-30, accession 0000950170-23-056121.Report this figure122Cash and equivalents, FY2023, at 2023-12-31$121.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2025-02-27, accession 0000950170-25-028356.Report this figure272Cash and equivalents, Q1 FY2024, at 2024-03-31$272.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-05-02, accession 0000950170-24-052066.Report this figure608Cash and equivalents, Q2 FY2024, at 2024-06-30$608.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-08-12, accession 0000950170-24-095527.Report this figure532Cash and equivalents, Q3 FY2024, at 2024-09-30$532.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2024-11-12, accession 0000950170-24-124572.Report this figure435Cash and equivalents, FY2024, at 2024-12-31$435.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-02, accession 0001193125-26-084178.Report this figure472Cash and equivalents, Q1 FY2025, at 2025-03-31$472.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-05-08, accession 0000950170-25-066386.Report this figure485Cash and equivalents, Q2 FY2025, at 2025-06-30$485.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-07-28, accession 0000950170-25-099161.Report this figure574Cash and equivalents, Q3 FY2025, at 2025-09-30$573.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure893Cash and equivalents, FY2025, at 2025-12-31$893.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure753Cash and equivalents, Q1 FY2026, at 2026-03-31$753.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure676Cash and equivalents, Q2 FY2026, at 2026-06-30$676.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure
Current assets$m168Current assets, Q3 FY2023, at 2023-09-30$168.2m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2023-10-30, accession 0000950170-23-056121.Report this figure129Current assets, FY2023, at 2023-12-31$129.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2025-02-27, accession 0000950170-25-028356.Report this figure488Current assets, Q1 FY2024, at 2024-03-31$488.1m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-05-02, accession 0000950170-24-052066.Report this figure792Current assets, Q2 FY2024, at 2024-06-30$792.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095527.Report this figure736Current assets, Q3 FY2024, at 2024-09-30$736.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124572.Report this figure659Current assets, FY2024, at 2024-12-31$659.3m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-02, accession 0001193125-26-084178.Report this figure690Current assets, Q1 FY2025, at 2025-03-31$689.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066386.Report this figure698Current assets, Q2 FY2025, at 2025-06-30$698.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-07-28, accession 0000950170-25-099161.Report this figure806Current assets, Q3 FY2025, at 2025-09-30$806.3m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure1,127Current assets, FY2025, at 2025-12-31$1.13bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure1,021Current assets, Q1 FY2026, at 2026-03-31$1.02bn. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure938Current assets, Q2 FY2026, at 2026-06-30$937.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure
Total assets$m205Total assets, Q3 FY2023, at 2023-09-30$205.2m. XBRL concept us-gaap:Assets. 10-Q filed 2023-10-30, accession 0000950170-23-056121.Report this figure165Total assets, FY2023, at 2023-12-31$165.1m. XBRL concept us-gaap:Assets. 10-K filed 2025-02-27, accession 0000950170-25-028356.Report this figure522Total assets, Q1 FY2024, at 2024-03-31$522.3m. XBRL concept us-gaap:Assets. 10-Q filed 2024-05-02, accession 0000950170-24-052066.Report this figure826Total assets, Q2 FY2024, at 2024-06-30$825.9m. XBRL concept us-gaap:Assets. 10-Q filed 2024-08-12, accession 0000950170-24-095527.Report this figure769Total assets, Q3 FY2024, at 2024-09-30$768.8m. XBRL concept us-gaap:Assets. 10-Q filed 2024-11-12, accession 0000950170-24-124572.Report this figure691Total assets, FY2024, at 2024-12-31$691.2m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-02, accession 0001193125-26-084178.Report this figure721Total assets, Q1 FY2025, at 2025-03-31$721.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-05-08, accession 0000950170-25-066386.Report this figure729Total assets, Q2 FY2025, at 2025-06-30$729.0m. XBRL concept us-gaap:Assets. 10-Q filed 2025-07-28, accession 0000950170-25-099161.Report this figure867Total assets, Q3 FY2025, at 2025-09-30$867.1m. XBRL concept us-gaap:Assets. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure1,187Total assets, FY2025, at 2025-12-31$1.19bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure1,080Total assets, Q1 FY2026, at 2026-03-31$1.08bn. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure994Total assets, Q2 FY2026, at 2026-06-30$994.0m. XBRL concept us-gaap:Assets. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure
Current liabilities$m29.7Current liabilities, Q3 FY2023, at 2023-09-30$29.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2023-10-30, accession 0000950170-23-056121.Report this figure51.1Current liabilities, FY2023, at 2023-12-31$51.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2025-02-27, accession 0000950170-25-028356.Report this figure22.4Current liabilities, Q1 FY2024, at 2024-03-31$22.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-05-02, accession 0000950170-24-052066.Report this figure29.8Current liabilities, Q2 FY2024, at 2024-06-30$29.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-08-12, accession 0000950170-24-095527.Report this figure43.3Current liabilities, Q3 FY2024, at 2024-09-30$43.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2024-11-12, accession 0000950170-24-124572.Report this figure42.3Current liabilities, FY2024, at 2024-12-31$42.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-02, accession 0001193125-26-084178.Report this figure33.9Current liabilities, Q1 FY2025, at 2025-03-31$33.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-05-08, accession 0000950170-25-066386.Report this figure41.5Current liabilities, Q2 FY2025, at 2025-06-30$41.5m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-07-28, accession 0000950170-25-099161.Report this figure59.8Current liabilities, Q3 FY2025, at 2025-09-30$59.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure50.6Current liabilities, FY2025, at 2025-12-31$50.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure51.2Current liabilities, Q1 FY2026, at 2026-03-31$51.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure78.0Current liabilities, Q2 FY2026, at 2026-06-30$78.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure
Total liabilities$m53.2Total liabilities, Q3 FY2023, at 2023-09-30$53.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2023-10-30, accession 0000950170-23-056121.Report this figure73.8Total liabilities, FY2023, at 2023-12-31$73.8m. XBRL concept us-gaap:Liabilities. 10-K filed 2025-02-27, accession 0000950170-25-028356.Report this figure44.2Total liabilities, Q1 FY2024, at 2024-03-31$44.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-05-02, accession 0000950170-24-052066.Report this figure50.7Total liabilities, Q2 FY2024, at 2024-06-30$50.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-08-12, accession 0000950170-24-095527.Report this figure63.3Total liabilities, Q3 FY2024, at 2024-09-30$63.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2024-11-12, accession 0000950170-24-124572.Report this figure61.4Total liabilities, FY2024, at 2024-12-31$61.4m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-02, accession 0001193125-26-084178.Report this figure52.1Total liabilities, Q1 FY2025, at 2025-03-31$52.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-05-08, accession 0000950170-25-066386.Report this figure158Total liabilities, Q2 FY2025, at 2025-06-30$157.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-07-28, accession 0000950170-25-099161.Report this figure175Total liabilities, Q3 FY2025, at 2025-09-30$175.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure215Total liabilities, FY2025, at 2025-12-31$214.8m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure215Total liabilities, Q1 FY2026, at 2026-03-31$214.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure292Total liabilities, Q2 FY2026, at 2026-06-30$291.9m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure
Long-term debt$mnot reportednot reportednot reportednot reportednot reported0.0Long-term debt, FY2024, at 2024-12-31$0. XBRL concept us-gaap:LongTermDebt. 10-K filed 2026-03-02, accession 0001193125-26-084178.Report this figurenot reported98.8Long-term debt, Q2 FY2025, at 2025-06-30$98.8m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-07-28, accession 0000950170-25-099161.Report this figure99.1Long-term debt, Q3 FY2025, at 2025-09-30$99.1m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure149Long-term debt, FY2025, at 2025-12-31$148.9m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure149Long-term debt, Q1 FY2026, at 2026-03-31$149.4m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure199Long-term debt, Q2 FY2026, at 2026-06-30$199.3m. XBRL concept us-gaap:LongTermDebt. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure
Shareholders' equity$m152Shareholders' equity, Q3 FY2023, at 2023-09-30$152.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2024-11-12, accession 0000950170-24-124572.Report this figure91.3Shareholders' equity, FY2023, at 2023-12-31$91.3m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-02, accession 0001193125-26-084178.Report this figure478Shareholders' equity, Q1 FY2024, at 2024-03-31$478.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure775Shareholders' equity, Q2 FY2024, at 2024-06-30$775.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure706Shareholders' equity, Q3 FY2024, at 2024-09-30$705.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure630Shareholders' equity, FY2024, at 2024-12-31$629.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure669Shareholders' equity, Q1 FY2025, at 2025-03-31$669.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure571Shareholders' equity, Q2 FY2025, at 2025-06-30$571.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure692Shareholders' equity, Q3 FY2025, at 2025-09-30$691.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2025-11-05, accession 0001193125-25-266882.Report this figure972Shareholders' equity, FY2025, at 2025-12-31$972.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure865Shareholders' equity, Q1 FY2026, at 2026-03-31$865.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure702Shareholders' equity, Q2 FY2026, at 2026-06-30$702.2m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-07-29, accession 0001193125-26-323639.Report this figure

Cash flow

Operating cash flow−$130.3m, Q2 FY2026
Capital expenditure$1.5m, Q2 FY2026
Dyne Therapeutics, Inc., cash flow, quarterly
Line itemUnitQ3 FY20232023-09-30Q4 FY20232023-12-31Q1 FY20242024-03-31Q2 FY20242024-06-30Q3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(50.6)Operating cash flow, Q3 FY2023, three months to 2023-09-30−$50.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2024-11-12, accession 0000950170-24-124572. Derived: 9-month figure less the 6-month figure.Report this figure(35.0)Operating cash flow, Q4 FY2023, three months to 2023-12-31−$35.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure(78.5)Operating cash flow, Q1 FY2024, three months to 2024-03-31−$78.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-05-08, accession 0000950170-25-066386.Report this figure(54.9)Operating cash flow, Q2 FY2024, three months to 2024-06-30−$54.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-07-28, accession 0000950170-25-099161. Derived: 6-month figure less the 3-month figure.Report this figure(74.6)Operating cash flow, Q3 FY2024, three months to 2024-09-30−$74.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266882. Derived: 9-month figure less the 6-month figure.Report this figure(84.3)Operating cash flow, Q4 FY2024, three months to 2024-12-31−$84.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure(106)Operating cash flow, Q1 FY2025, three months to 2025-03-31−$105.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure(94.7)Operating cash flow, Q2 FY2025, three months to 2025-06-30−$94.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001193125-26-323639. Derived: 6-month figure less the 3-month figure.Report this figure(90.8)Operating cash flow, Q3 FY2025, three months to 2025-09-30−$90.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-05, accession 0001193125-25-266882. Derived: 9-month figure less the 6-month figure.Report this figure(112)Operating cash flow, Q4 FY2025, three months to 2025-12-31−$111.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure(145)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$144.9m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure(130)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$130.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-07-29, accession 0001193125-26-323639. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, Q3 FY2023, three months to 2023-09-30$167.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2024-11-12, accession 0000950170-24-124572. Derived: 9-month figure less the 6-month figure.Report this figure0.1Capital expenditure, Q4 FY2023, three months to 2023-12-31$82.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2024, three months to 2024-03-31$191.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-05-08, accession 0000950170-25-066386.Report this figure0.9Capital expenditure, Q2 FY2024, three months to 2024-06-30$857.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-07-28, accession 0000950170-25-099161. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q3 FY2024, three months to 2024-09-30$253.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266882. Derived: 9-month figure less the 6-month figure.Report this figure1.1Capital expenditure, Q4 FY2024, three months to 2024-12-31$1.1m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure1.0Capital expenditure, Q1 FY2025, three months to 2025-03-31$981.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure0.1Capital expenditure, Q2 FY2025, three months to 2025-06-30$60.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001193125-26-323639. Derived: 6-month figure less the 3-month figure.Report this figure0.4Capital expenditure, Q3 FY2025, three months to 2025-09-30$395.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-05, accession 0001193125-25-266882. Derived: 9-month figure less the 6-month figure.Report this figure0.5Capital expenditure, Q4 FY2025, three months to 2025-12-31$484.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-03-02, accession 0001193125-26-084178. Derived: 12-month figure less the 9-month figure.Report this figure0.2Capital expenditure, Q1 FY2026, three months to 2026-03-31$221.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001193125-26-215702.Report this figure1.5Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.5m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-07-29, accession 0001193125-26-323639. Derived: 6-month figure less the 3-month figure.Report this figure

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. Listed shows no prices and gives no investment advice.